Prohibiting, beginning July 1, 2025, the use of State funds to purchase opioid overdose reversal drugs from a person that was party to a settlement with any state due to its role in the manufacture, sale, or distribution of prescription opioids; making certain exceptions; and prohibiting certain State contracts from being renewed on or after July 1, 2025.